News
PSMA and Beyond 2025 CA-IX in renal cell cancer (RCC), ZIRCON, kidney cancer, stage migration for RCC, REDECT trial, renal mass biopsy, girentuximab.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback